Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
This study is currently recruiting participants.
Verified February 2013 by Cerexa, Inc.
Study NCT01530763   Information provided by Cerexa, Inc.

First Received on February 8, 2012.   Last Updated on February 12, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infections
Community Acquired Pneumonia
Additional conditions recognized in this trial
Pneumonia
Pneumonia, Bacterial
More general conditions related to this trial
Bacterial Infections
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Ceftaroline fosamil
Ceftriaxone
amoxicillin clavulanate
Additional drug interventions recognized in this trial
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Clavulanic Acid
Clavulanic Acids
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Cerexa, Inc.
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services